Literature DB >> 14563376

Association between IL-1beta -511C/T and IL-1RA (86bp)n repeats polymorphisms and schizophrenia.

Roberta Zanardini1, Luisella Bocchio-Chiavetto, Catia Scassellati, Cristian Bonvicini, Gian Battista Tura, Giuseppe Rossi, Jorge Perez, Massimo Gennarelli.   

Abstract

It has been established that cytokines play a critical role in the regulation of the CNS and recent studies have suggested that dysfunctions of both pro-inflammatory (IL-1beta, IL-6, and TNF-alpha) and anti-inflammatory (IL-1RA and IL-10) cytokines could be involved in the pathophysiology of schizophrenia. Previous studies have reported that functional polymorphisms in some cytokines genes may have important regulatory effects on such system. Therefore, the aim of the present study was to explore the possible role of the IL-1beta -511C/T and IL-1RA (86bp)(n) repeats polymorphisms in schizophrenia. A case control association study comparing genotype and allele frequencies in 346 northen Italian subjects (169 schizophrenic patients and 177 unrelated healthy volunteers) was performed. The frequencies of IL-1beta -511C and IL-1RA allele 1 (86bp)(4) are significantly higher in schizophrenic patients compared to controls (IL-1beta -511 P=0.047; IL-1RA (86bp)(n) P=0.002). Moreover our data show a protective effect of the IL-1RA allele 2 (86bp)(2) against schizophrenia (OR=0.59 95%CI:0.388-0.910; P=0.016) and this effect is enhanced by the concomitant presence of IL-1beta -511T (OR=0.48 95%CI:0.30-0.76; P=0.002). Our findings support the hypothesis that genetically determined changes in IL-1 metabolism regulation may contribute to the pathogenesis of schizophrenia confirming a role of IL-1 gene cluster in disease susceptibility.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14563376     DOI: 10.1016/s0022-3956(03)00072-4

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  10 in total

Review 1.  A review of the fetal brain cytokine imbalance hypothesis of schizophrenia.

Authors:  Urs Meyer; Joram Feldon; Benjamin K Yee
Journal:  Schizophr Bull       Date:  2008-04-11       Impact factor: 9.306

Review 2.  [Correlations between risk gene variants for schizophrenia and brain structure anomalies].

Authors:  T Nickl-Jockschat; M Rietschel; T Kircher
Journal:  Nervenarzt       Date:  2009-01       Impact factor: 1.214

3.  Genetic analysis of interleukin-1 receptor antagonist and interleukin-1β single-nucleotide polymorphisms C-511T and C+3953T in alopecia areata: susceptibility and severity association.

Authors:  Suad Alfadhli; Arti Nanda
Journal:  Clin Exp Med       Date:  2013-04-13       Impact factor: 3.984

4.  Association study of CSF2RB with schizophrenia in Irish family and case - control samples.

Authors:  Q Chen; X Wang; F A O'Neill; D Walsh; A Fanous; K S Kendler; X Chen
Journal:  Mol Psychiatry       Date:  2007-07-31       Impact factor: 15.992

5.  Interleukin-1 beta gene polymorphism and its interactions with neuregulin-1 gene polymorphism are associated with schizophrenia.

Authors:  Kari Hänninen; Heikki Katila; Marika Saarela; Riikka Rontu; Kari M Mattila; Meng Fan; Mikko Hurme; Terho Lehtimäki
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-09-27       Impact factor: 5.270

Review 6.  Evidence for a dysregulated immune system in the etiology of psychiatric disorders.

Authors:  Sinead M Gibney; Hemmo A Drexhage
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-05       Impact factor: 4.147

7.  Possible association between interleukin-1β gene and schizophrenia in a Japanese population.

Authors:  Daimei Sasayama; Hiroaki Hori; Toshiya Teraishi; Kotaro Hattori; Miho Ota; Yoshimi Iijima; Masahiko Tatsumi; Teruhiko Higuchi; Naoji Amano; Hiroshi Kunugi
Journal:  Behav Brain Funct       Date:  2011-08-16       Impact factor: 3.759

8.  Cryoglobulins as potential triggers of inflammation in schizophrenia.

Authors:  Andranik Chavushyan; Meri Hovsepyan; Anna Boyajyan
Journal:  Schizophr Res Treatment       Date:  2013-12-15

9.  Increased serum interleukin-1beta and interleukin-6 in elderly, chronic schizophrenic patients on stable antipsychotic medication.

Authors:  Andrea Schmitt; Thomas Bertsch; Heike Tost; Andrea Bergmann; Uwe Henning; Ansgar Klimke; Peter Falkai
Journal:  Neuropsychiatr Dis Treat       Date:  2005-06       Impact factor: 2.570

Review 10.  The neuroimmunology of schizophrenia.

Authors:  Annya M Smyth; Stephen M Lawrie
Journal:  Clin Psychopharmacol Neurosci       Date:  2013-12-24       Impact factor: 2.582

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.